Shivakoti Rupak, Christian Parul, Yang Wei-Teng, Gupte Nikhil, Mwelase Noluthando, Kanyama Cecilia, Pillay Sandy, Samaneka Wadzanai, Santos Breno, Poongulali Selvamuthu, Tripathy Srikanth, Riviere Cynthia, Berendes Sima, Lama Javier R, Cardoso Sandra W, Sugandhavesa Patcharaphan, Tang Alice M, Semba Richard D, Campbell Thomas B, Gupta Amita
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
Clin Nutr. 2016 Feb;35(1):183-189. doi: 10.1016/j.clnu.2015.02.002. Epub 2015 Feb 10.
BACKGROUND & AIMS: HIV-infected adults have increased risk of several individual micronutrient deficiencies. However, the prevalence and risk factors of concurrent and multiple micronutrient deficiencies and whether micronutrient concentrations change after antiretroviral therapy (ART) initiation have not been well described. The objective of this study was to determine the prevalence and risk factors of individual, concurrent and multiple micronutrient deficiencies among ART-naïve HIV-infected adults from nine countries and assess change in micronutrient status 48 weeks post-ART initiation.
A random sub-cohort (n = 270) stratified by country was selected from the multinational PEARLS clinical trial (n = 1571 ART-naïve, HIV-infected adults). We measured serum concentrations of vitamins A, D (25-hydroxyvitamin), E, carotenoids and selenium pre-ART and 48 weeks post-ART initiation, and measured vitamins B6, B12, ferritin and soluble transferrin receptor at baseline only. Prevalence of single micronutrient deficiencies, concurrent (2 coexisting) or conditional (a deficiency in one micronutrient given a deficiency in another) and multiple (≥3) were determined using defined serum concentration cutoffs. We assessed mean changes in micronutrient concentrations from pre-ART to week 48 post-ART initiation using multivariable random effects models.
Of 270 participants, 13.9%, 29.2%, 24.5% and 32.4% had 0, 1, 2 and multiple deficiencies, respectively. Pre-ART prevalence was the highest for single deficiencies of selenium (53.2%), vitamin D (42.4%), and B6 (37.3%) with 12.1% having concurrent deficiencies of all three micronutrients. Deficiency prevalence varied widely by country. 48 weeks post-ART initiation, mean vitamin A concentration increased (p < 0.001) corresponding to a 9% decrease in deficiency. Mean concentrations also increased for other micronutrients assessed 48 weeks post-ART (p < 0.001) but with minimal change in deficiency status.
Single and multiple micronutrient deficiencies are common among HIV-infected adults pre-ART initiation but vary between countries. Importantly, despite increases in micronutrient concentrations, prevalence of individual deficiencies remains largely unchanged after 48 weeks on ART. Our results suggest that ART alone is not sufficient to improve micronutrient deficiency.
感染HIV的成年人患多种个体微量营养素缺乏症的风险增加。然而,合并和多种微量营养素缺乏症的患病率及危险因素,以及在开始抗逆转录病毒治疗(ART)后微量营养素浓度是否会发生变化,目前尚未得到充分描述。本研究的目的是确定来自9个国家的未接受过ART治疗的HIV感染成年人中个体、合并和多种微量营养素缺乏症的患病率及危险因素,并评估开始ART治疗48周后微量营养素状况的变化。
从多国PEARLS临床试验(n = 1571名未接受过ART治疗的HIV感染成年人)中按国家分层随机抽取一个亚队列(n = 270)。我们在开始ART治疗前和开始治疗48周后测量了血清中维生素A、D(25-羟基维生素)、E、类胡萝卜素和硒的浓度,仅在基线时测量了维生素B6、B12、铁蛋白和可溶性转铁蛋白受体。使用定义的血清浓度临界值确定单一微量营养素缺乏症、合并(两种同时存在)或条件性(在一种微量营养素缺乏的情况下另一种微量营养素缺乏)和多种(≥3种)缺乏症的患病率。我们使用多变量随机效应模型评估从开始ART治疗前到开始治疗48周后微量营养素浓度的平均变化。
在270名参与者中,分别有13.9%、29.2%、24.5%和32.4%的人有0种、1种、2种和多种缺乏症。开始ART治疗前,单一缺乏症中硒(53.2%)、维生素D(42.4%)和B6(37.3%)的患病率最高,12.1%的人同时缺乏这三种微量营养素。缺乏症患病率因国家而异。开始ART治疗48周后,维生素A的平均浓度升高(p < 0.001),相应的缺乏症减少了9%。开始ART治疗48周后评估的其他微量营养素的平均浓度也有所升高(p < 0.001),但缺乏症状况变化最小。
在开始ART治疗前,单一和多种微量营养素缺乏症在HIV感染成年人中很常见,但因国家而异。重要的是,尽管微量营养素浓度有所升高,但在接受ART治疗48周后,个体缺乏症的患病率基本保持不变。我们的结果表明,仅ART治疗不足以改善微量营养素缺乏症。